ResearcherUniversity of North Carolina at Chapel HillNo recent work listed
Daniel Zeitouni
Matched on ORCID iD 0000-0003-3856-1623; OpenAlex author ID A5073474871. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper
Papers 3
- Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Co-author DOI 10.1038/s41591-020-0947-8↗
- Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Co-author DOI 10.1038/s41591-019-0368-8↗
- KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment. Co-author DOI 10.3390/cancers8040045↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kirsten L. Bryant · 3 shared papers, 2016–2020 · strength 0.22
- Paper KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment. DOI 10.3390/cancers8040045↗
- Paper Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. DOI 10.1038/s41591-020-0947-8↗
- Paper Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. DOI 10.1038/s41591-019-0368-8↗
- Channing J. Der · 3 shared papers, 2016–2020 · strength 0.22
- Paper KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment. DOI 10.3390/cancers8040045↗
- Paper Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. DOI 10.1038/s41591-020-0947-8↗
- Paper Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. DOI 10.1038/s41591-019-0368-8↗
- Bjoern Papke · 2 shared papers, 2019–2020 · strength 0.14
- Emanuel F. Petricoin · 2 shared papers, 2019–2020 · strength 0.14
- Nina V. Chaika · 2 shared papers, 2019–2020 · strength 0.14
- Yan Liang · 2 shared papers, 2019–2020 · strength 0.14
- J. Nathaniel Diehl · 2 shared papers, 2019–2020 · strength 0.14
- Venugopal Gunda · 2 shared papers, 2019–2020 · strength 0.14
- Mariaelena Pierobon · 2 shared papers, 2019–2020 · strength 0.14
- Yingxue Wang · 2 shared papers, 2019–2020 · strength 0.14
- Haoqiang Ying · 2 shared papers, 2019–2020 · strength 0.14
- Adrienne D. Cox · 2 shared papers, 2019–2020 · strength 0.14
- Erik S. Knudsen · 2 shared papers, 2019–2020 · strength 0.14
- Pankaj Kumar Singh · 2 shared papers, 2019–2020 · strength 0.14
- Jennifer E. Klomp · 2 shared papers, 2019–2020 · strength 0.14
- Agnieszka Katarzyna Witkiewicz · 2 shared papers, 2019–2020 · strength 0.14
- Alec C. Kimmelman · 2 shared papers, 2019–2020 · strength 0.14
- Clint A. Stalnecker · 2 shared papers, 2019–2020 · strength 0.14
- Andrew M. Waters · 2 shared papers, 2019–2020 · strength 0.14
- G. Aaron Hobbs · 2 shared papers, 2019–2020 · strength 0.14
- Tikvah K. Hayes · 2 shared papers, 2019–2020 · strength 0.14
- Costas Andreas Lyssiotis · 2 shared papers, 2019–2020 · strength 0.14
- Yuliya Pylayeva-Gupta · 1 shared paper, 2016 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.